Millennium Management’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
Other funds holding PYXS
Millennium Management's PYXS Position: Q3 2026 in Review
Millennium Management increased its Pyxis Oncology (PYXS) stake by 257% in Q3 2026, buying an estimated $1.81M and bringing the position to 831,700 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #3943.
Millennium Management first reported a position in PYXS in Q4 2021 and has held it in 17 quarters since. The position peaked at $7M in Q3 2024. 101 funds tracked by Wall St. Rank hold PYXS as of Q3 2026.
- Millennium Management held 831,700 shares of Pyxis Oncology worth $1.94M as of Q3 2026.
- Millennium Management bought 598,696 Pyxis Oncology shares in Q3 2026, an estimated $1.81M.
- Pyxis Oncology made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #3943 holding.
- Millennium Management first reported a position in Pyxis Oncology in Q4 2021 and has held it in 17 quarters since.
- Millennium Management's Pyxis Oncology position peaked at $7M in Q3 2024.
- 101 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.